Reckitt Benckiser ticks higher amid report activist Eminence Capital takes stake [Seeking Alpha]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Seeking Alpha
Eminence owns at least an 0.5% stake in Reckitt after it began purchased shares in March as they dropped towards an all-time low, according to a Financial Times report on Tuesday, which cited people familiar with the matter. Eminence purchased the shares after Reckitt shares plunged 15% in mid March after amid a jury verdict against the company over its Enfamil baby formula. The verdict is the first of hundreds of cases that have been filed against Mead Johnson and fellow infant formula maker Abbott ( ABT ) Over 400 cases involving NEC have been filed in Chicago federal court, with others pending in state courts, Reuters said in March. The Eminence stake is likely to increase calls for Reckitt CEO Kris Licht to push for a sale of the baby formula division, the people familiar told the FT. Recommended For You More Trending News Recommended For You More Trending News Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Declares 406th Consecutive Quarterly DividendPR Newswire
- Clinical Immunochemistry Analyzers Market projected reach USD 6.9 billion by 2034, growing at a CAGR of 4.4% | Exactitude Consultancy [Yahoo! Finance]Yahoo! Finance
- Multi-Blood Monitoring System Market is expected to reach USD 3.9 billion by 2034, with a 6.4% CAGR growth | Exactitude Consultancy [Yahoo! Finance]Yahoo! Finance
- 1 Mooning Stock with Exciting Potential and 2 to Think Twice About [Yahoo! Finance]Yahoo! Finance
- Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/16/25 - Beat
ABT
Sec Filings
- 5/29/25 - Form SD
- 5/2/25 - Form 4
- 5/1/25 - Form 8-K
- ABT's page on the SEC website